195 related articles for article (PubMed ID: 15082764)
1. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.
Baldwin BR; Timchenko NA; Zahnow CA
Mol Cell Biol; 2004 May; 24(9):3682-91. PubMed ID: 15082764
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
3. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
Li H; Baldwin BR; Zahnow CA
Mol Cancer; 2011 Aug; 10():100. PubMed ID: 21854628
[TBL] [Abstract][Full Text] [Related]
4. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.
Timchenko NA; Welm AL; Lu X; Timchenko LT
Nucleic Acids Res; 1999 Nov; 27(22):4517-25. PubMed ID: 10536163
[TBL] [Abstract][Full Text] [Related]
5. Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging.
Karagiannides I; Thomou T; Tchkonia T; Pirtskhalava T; Kypreos KE; Cartwright A; Dalagiorgou G; Lash TL; Farmer SR; Timchenko NA; Kirkland JL
J Biol Chem; 2006 Aug; 281(32):23025-33. PubMed ID: 16754681
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 and C/EBPβ LAP1 operate in a common pathway to promote mammary epithelial cell differentiation.
Liu Q; Boudot A; Ni J; Hennessey T; Beauparlant SL; Rajabi HN; Zahnow C; Ewen ME
Mol Cell Biol; 2014 Aug; 34(16):3168-79. PubMed ID: 24912680
[TBL] [Abstract][Full Text] [Related]
7. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2.
Timchenko NA; Wang GL; Timchenko LT
J Biol Chem; 2005 May; 280(21):20549-57. PubMed ID: 15788409
[TBL] [Abstract][Full Text] [Related]
8. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells.
Bundy L; Wells S; Sealy L
Mol Cancer; 2005 Dec; 4():43. PubMed ID: 16371159
[TBL] [Abstract][Full Text] [Related]
9. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
10. P53 regulates CCAAT/Enhancer binding protein β gene expression.
Hu B; Liu T; Wu Z; Phan SH
Gene; 2023 Oct; 884():147675. PubMed ID: 37541559
[TBL] [Abstract][Full Text] [Related]
11. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.
Timchenko NA; Cai ZJ; Welm AL; Reddy S; Ashizawa T; Timchenko LT
J Biol Chem; 2001 Mar; 276(11):7820-6. PubMed ID: 11124939
[TBL] [Abstract][Full Text] [Related]
12. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer binding protein beta (C/EBPβ) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells.
Miura Y; Hagiwara N; Radisky DC; Hirai Y
Exp Cell Res; 2014 Sep; 327(1):146-55. PubMed ID: 24881817
[TBL] [Abstract][Full Text] [Related]
14. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
15. EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform.
Selagea L; Mishra A; Anand M; Ross J; Tucker-Burden C; Kong J; Brat DJ
FASEB J; 2016 Dec; 30(12):4098-4108. PubMed ID: 27572958
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
Hansberg-Pastor V; González-Arenas A; Camacho-Arroyo I
Mol Cell Endocrinol; 2017 Jan; 439():317-327. PubMed ID: 27663075
[TBL] [Abstract][Full Text] [Related]
17. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.
Arnal-Estapé A; Tarragona M; Morales M; Guiu M; Nadal C; Massagué J; Gomis RR
Cancer Res; 2010 Dec; 70(23):9927-36. PubMed ID: 21098707
[TBL] [Abstract][Full Text] [Related]
18. C/EBPβ regulates P2X7 receptor expression in response to glucose challenge in intestinal epithelial cells.
Bilodeau MS; Arguin G; Gendron FP
Biochem Cell Biol; 2015 Feb; 93(1):38-46. PubMed ID: 25403356
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.
Chang ET; Donahue JM; Xiao L; Cui Y; Rao JN; Turner DJ; Twaddell WS; Wang JY; Battafarano RJ
Biochem J; 2012 Aug; 446(1):113-23. PubMed ID: 22646166
[TBL] [Abstract][Full Text] [Related]
20. CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages.
Dudaronek JM; Barber SA; Clements JE
J Immunol; 2007 Dec; 179(11):7262-9. PubMed ID: 18025168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
